AAPL314.14-2.08 (-0.66%) ▼|ABBV246.21-3.71 (-1.48%) ▼|ABT93.80-0.60 (-0.64%) ▼|ACN135.74-3.33 (-2.39%) ▼|ADBE223.11+0.46 (+0.20%) ▲|AMAT607.27+18.61 (+3.16%) ▲|AMD558.03+11.31 (+2.07%) ▲|AMGN361.52-2.10 (-0.58%) ▼|AMT167.24+2.24 (+1.35%) ▲|AMZN245.07-1.98 (-0.80%) ▼|AVGO399.73-1.39 (-0.35%) ▼|AXP350.20+3.48 (+1.00%) ▲|BA222.54-0.57 (-0.26%) ▼|BAC59.80+0.55 (+0.92%) ▲|BKNG178.45+2.93 (+1.67%) ▲|BLK1,035.05+15.37 (+1.51%) ▲|BMY57.29-0.65 (-1.11%) ▼|BNY151.89-0.37 (-0.24%) ▼|BRK-B492.62-2.83 (-0.57%) ▼|C140.99+1.42 (+1.01%) ▲|CAT956.59+18.20 (+1.94%) ▲|CL92.25+1.24 (+1.36%) ▲|CMCSA23.45+0.10 (+0.43%) ▲|COF201.16+1.06 (+0.53%) ▲|COP108.15+0.13 (+0.12%) ▲|COST914.50+1.53 (+0.17%) ▲|CRM162.92+0.42 (+0.26%) ▲|CSCO120.44+2.13 (+1.80%) ▲|CVS104.20+1.39 (+1.35%) ▲|CVX174.66+0.61 (+0.35%) ▲|DE592.71-0.20 (-0.03%) ▼|DHR198.07+2.09 (+1.07%) ▲|DIS96.01-0.16 (-0.17%) ▼|DUK124.95-0.31 (-0.25%) ▼|EMR139.62+1.82 (+1.32%) ▲|FDX314.22+3.38 (+1.09%) ▲|GD373.66-0.94 (-0.25%) ▼|GE359.96+0.92 (+0.26%) ▲|GEV1,100.30+25.04 (+2.33%) ▲|GILD129.90-4.94 (-3.66%) ▼|GM78.49+1.84 (+2.40%) ▲|GOOG353.04-3.20 (-0.90%) ▼|GOOGL355.32-3.57 (-0.99%) ▼|GS1,058.81+2.84 (+0.27%) ▲|HD343.02+4.29 (+1.27%) ▲|HON227.40+3.98 (+1.78%) ▲|IBM289.49-5.81 (-1.97%) ▼|INTC110.16-2.38 (-2.11%) ▼|INTU273.31-0.07 (-0.03%) ▼|ISRG403.94-7.61 (-1.85%) ▼|JNJ256.32-2.78 (-1.07%) ▼|JPM336.54+1.07 (+0.32%) ▲|KO83.35+0.72 (+0.87%) ▲|LIN531.55+5.99 (+1.14%) ▲|LLY1,183.88-33.07 (-2.72%) ▼|LMT519.46+1.20 (+0.23%) ▲|LOW213.23+0.23 (+0.11%) ▲|LRCX353.44+0.27 (+0.08%) ▲|MA521.38-1.83 (-0.35%) ▼|MCD276.75+0.26 (+0.09%) ▲|MDLZ58.72+0.42 (+0.71%) ▲|MDT83.55+1.16 (+1.41%) ▲|META668.23+36.75 (+5.82%) ▲|MMM157.80+2.46 (+1.58%) ▲|MO71.60+0.01 (+0.01%) ▲|MRK123.20-1.87 (-1.50%) ▼|MS222.61+0.48 (+0.21%) ▲|MSFT383.94-0.42 (-0.11%) ▼|MU991.99+0.35 (+0.04%) ▲|NEE87.26+0.16 (+0.18%) ▲|NFLX73.18-2.29 (-3.03%) ▼|NKE44.58+1.80 (+4.20%) ▲|NOW107.16-1.69 (-1.55%) ▼|NVDA210.20+7.42 (+3.66%) ▲|ORCL141.45-2.27 (-1.58%) ▼|PEP137.05-0.81 (-0.59%) ▼|PFE24.25+0.00 (+0.00%) ▲|PG147.09+0.24 (+0.16%) ▲|PLTR126.68-2.37 (-1.83%) ▼|PM180.81-0.36 (-0.20%) ▼|QCOM189.18-1.93 (-1.01%) ▼|RTX195.68+0.48 (+0.25%) ▲|SBUX106.96+0.55 (+0.52%) ▲|SCHW102.66+0.75 (+0.74%) ▲|SO95.34+0.17 (+0.17%) ▲|SPG215.88-3.84 (-1.75%) ▼|T21.13+0.36 (+1.75%) ▲|TMO524.82+0.11 (+0.02%) ▲|TMUS185.86+4.38 (+2.41%) ▲|TSLA409.88+3.33 (+0.82%) ▲|TXN311.48+2.95 (+0.96%) ▲|UBER74.78+0.43 (+0.58%) ▲|UNH424.78-6.90 (-1.60%) ▼|UNP288.49+3.45 (+1.21%) ▲|UPS112.67+1.93 (+1.74%) ▲|USB62.59+0.69 (+1.11%) ▲|V346.68-1.53 (-0.44%) ▼|VZ42.29+0.75 (+1.81%) ▲|WFC87.17+0.26 (+0.30%) ▲|WMT113.75+1.54 (+1.37%) ▲|XOM137.91+0.45 (+0.32%) ▲|AAPL314.14-2.08 (-0.66%) ▼|ABBV246.21-3.71 (-1.48%) ▼|ABT93.80-0.60 (-0.64%) ▼|ACN135.74-3.33 (-2.39%) ▼|ADBE223.11+0.46 (+0.20%) ▲|AMAT607.27+18.61 (+3.16%) ▲|AMD558.03+11.31 (+2.07%) ▲|AMGN361.52-2.10 (-0.58%) ▼|AMT167.24+2.24 (+1.35%) ▲|AMZN245.07-1.98 (-0.80%) ▼|AVGO399.73-1.39 (-0.35%) ▼|AXP350.20+3.48 (+1.00%) ▲|BA222.54-0.57 (-0.26%) ▼|BAC59.80+0.55 (+0.92%) ▲|BKNG178.45+2.93 (+1.67%) ▲|BLK1,035.05+15.37 (+1.51%) ▲|BMY57.29-0.65 (-1.11%) ▼|BNY151.89-0.37 (-0.24%) ▼|BRK-B492.62-2.83 (-0.57%) ▼|C140.99+1.42 (+1.01%) ▲|CAT956.59+18.20 (+1.94%) ▲|CL92.25+1.24 (+1.36%) ▲|CMCSA23.45+0.10 (+0.43%) ▲|COF201.16+1.06 (+0.53%) ▲|COP108.15+0.13 (+0.12%) ▲|COST914.50+1.53 (+0.17%) ▲|CRM162.92+0.42 (+0.26%) ▲|CSCO120.44+2.13 (+1.80%) ▲|CVS104.20+1.39 (+1.35%) ▲|CVX174.66+0.61 (+0.35%) ▲|DE592.71-0.20 (-0.03%) ▼|DHR198.07+2.09 (+1.07%) ▲|DIS96.01-0.16 (-0.17%) ▼|DUK124.95-0.31 (-0.25%) ▼|EMR139.62+1.82 (+1.32%) ▲|FDX314.22+3.38 (+1.09%) ▲|GD373.66-0.94 (-0.25%) ▼|GE359.96+0.92 (+0.26%) ▲|GEV1,100.30+25.04 (+2.33%) ▲|GILD129.90-4.94 (-3.66%) ▼|GM78.49+1.84 (+2.40%) ▲|GOOG353.04-3.20 (-0.90%) ▼|GOOGL355.32-3.57 (-0.99%) ▼|GS1,058.81+2.84 (+0.27%) ▲|HD343.02+4.29 (+1.27%) ▲|HON227.40+3.98 (+1.78%) ▲|IBM289.49-5.81 (-1.97%) ▼|INTC110.16-2.38 (-2.11%) ▼|INTU273.31-0.07 (-0.03%) ▼|ISRG403.94-7.61 (-1.85%) ▼|JNJ256.32-2.78 (-1.07%) ▼|JPM336.54+1.07 (+0.32%) ▲|KO83.35+0.72 (+0.87%) ▲|LIN531.55+5.99 (+1.14%) ▲|LLY1,183.88-33.07 (-2.72%) ▼|LMT519.46+1.20 (+0.23%) ▲|LOW213.23+0.23 (+0.11%) ▲|LRCX353.44+0.27 (+0.08%) ▲|MA521.38-1.83 (-0.35%) ▼|MCD276.75+0.26 (+0.09%) ▲|MDLZ58.72+0.42 (+0.71%) ▲|MDT83.55+1.16 (+1.41%) ▲|META668.23+36.75 (+5.82%) ▲|MMM157.80+2.46 (+1.58%) ▲|MO71.60+0.01 (+0.01%) ▲|MRK123.20-1.87 (-1.50%) ▼|MS222.61+0.48 (+0.21%) ▲|MSFT383.94-0.42 (-0.11%) ▼|MU991.99+0.35 (+0.04%) ▲|NEE87.26+0.16 (+0.18%) ▲|NFLX73.18-2.29 (-3.03%) ▼|NKE44.58+1.80 (+4.20%) ▲|NOW107.16-1.69 (-1.55%) ▼|NVDA210.20+7.42 (+3.66%) ▲|ORCL141.45-2.27 (-1.58%) ▼|PEP137.05-0.81 (-0.59%) ▼|PFE24.25+0.00 (+0.00%) ▲|PG147.09+0.24 (+0.16%) ▲|PLTR126.68-2.37 (-1.83%) ▼|PM180.81-0.36 (-0.20%) ▼|QCOM189.18-1.93 (-1.01%) ▼|RTX195.68+0.48 (+0.25%) ▲|SBUX106.96+0.55 (+0.52%) ▲|SCHW102.66+0.75 (+0.74%) ▲|SO95.34+0.17 (+0.17%) ▲|SPG215.88-3.84 (-1.75%) ▼|T21.13+0.36 (+1.75%) ▲|TMO524.82+0.11 (+0.02%) ▲|TMUS185.86+4.38 (+2.41%) ▲|TSLA409.88+3.33 (+0.82%) ▲|TXN311.48+2.95 (+0.96%) ▲|UBER74.78+0.43 (+0.58%) ▲|UNH424.78-6.90 (-1.60%) ▼|UNP288.49+3.45 (+1.21%) ▲|UPS112.67+1.93 (+1.74%) ▲|USB62.59+0.69 (+1.11%) ▲|V346.68-1.53 (-0.44%) ▼|VZ42.29+0.75 (+1.81%) ▲|WFC87.17+0.26 (+0.30%) ▲|WMT113.75+1.54 (+1.37%) ▲|XOM137.91+0.45 (+0.32%) ▲|
29.8 C
New York
Friday, July 10, 2026

Tag: development

New Azul and ITAM Forum Survey Reveals 1 in 4 Organizations Spend More Than $500,000 Annually Resolving Software License Non-Compliance

73% of enterprises have experienced an Oracle Java audit within the last three years and almost 8 in 10 organizations have migrated, or plan...

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully...

Frontera Announces Normal Course Issuer Bid

Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares CALGARY, AB, July 15, 2025 /PRNewswire/ - Frontera...

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”), has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing capabilities.

Markel appoints Chelsea Jiang as Managing Director – Greater China

SINGAPORE, July 15, 2025 /PRNewswire/ -- Markel Insurance, the insurance operations within Markel Group Inc. (NYSE: MKL), today announced the appointment of Chelsea Jiang...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

TOKYO, July 15, 2025 /PRNewswire/ -- TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, has developed an end-to-end architecture...

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 15, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for...

Frontera Announces Normal Course Issuer Bid

Frontera May Purchase up to 3,502,962 Common Shares Representing Approximately 5% of the Company's Issued and Outstanding Common Shares CALGARY, AB, July 15, 2025 /CNW/ - Frontera...

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

FebriDx® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient...

Fly-E Group, Inc. Announces Fiscal Year 2025 Financial Results

NEW YORK, July 15, 2025 /PRNewswire/ -- Fly-E Group, Inc. (Nasdaq: FLYE) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing,...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /CNW/ -- BioVaxys...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment